SCHEMBL28508762

SCHEMBL28508762

O=CNOC(=O)CCCCCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.48
LMNA P02545 3/20 0.48
NFKB1 P19838 1/20 0.48
PMP22 Q01453 1/20 0.48
GPR84 Q9NQS5 7/20 0.41
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.41
ALDH1A1 P00352 4/20 0.41
ABCC4 O15439 1/20 0.41
MAPT P10636 1/20 0.41
PRMT1 Q99873 1/20 0.41
PPARG P37231 6/20 0.40
PPARD Q03181 6/20 0.40
PPARA Q07869 6/20 0.40
HDAC11 Q96DB2 5/20 0.40
TLR2 O60603 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 2/20 0.40
FABP4 P15090 2/20 0.40
ALOX15 P16050 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10699569 0.92 LMNA (0.41) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL26907179 0.85 EGLN1 (0.41) TSHRLMNANFKB1PMP22SLC22A6
SCHEMBL28165411 0.85 TSHR (0.46) TSHRLMNAALDH1A1MEN1KMT2A
SCHEMBL27482958 0.82 DGKA (0.52) TSHRLMNAGPR84FFAR1FFAR4
SCHEMBL27700699 0.82 DGKA (0.52) TSHRLMNAGPR84FFAR1FFAR4
SCHEMBL28360017 0.82 DGKA (0.52) TSHRLMNAGPR84FFAR1FFAR4
SCHEMBL29169676 0.82 DGKA (0.52) TSHRLMNAGPR84FFAR1FFAR4
SCHEMBL29199661 0.82 DGKA (0.52) TSHRLMNAGPR84FFAR1FFAR4
Hydrochloric Acid SCHEMBL28914870 0.81 CNR2 (0.50) TSHRLMNAGPR84ALDH1A1MAPT
SCHEMBL27358889 0.80 ALDH1A1 (0.40) TSHRLMNAALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355020-A Therapeutic compounds for HIV virus infection 吉利德科学公司 2024-07-16 CN disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
CN-114555123-B Combination therapy for the treatment of myelodysplastic syndrome and acute myeloid leukemia 四十七公司 2024-04-02 CN disclosed
CN-117736207-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
CN-115362003-B Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
CN-117480155-A Diacylglycerol kinase modulating compounds 吉利德科学公司 2024-01-30 CN disclosed
CN-117396478-A Diacylglycerol kinase modulating compounds 吉利德科学公司 2024-01-12 CN disclosed
CN-117377671-A Diacylglycerol kinase modulating compounds 吉利德科学公司 2024-01-09 CN disclosed
CN-117355531-A Diacylglycerol kinase modulating compounds 吉利德科学公司 2024-01-05 CN disclosed
CN-117120474-A Co-inhibition of CD 47/SIRPalpha binding and NEDD8 activating enzyme E1 regulatory subunit for the treatment of cancer 吉利德科学公司 2023-11-24 CN disclosed
CN-116529258-A Interleukin-2-Fc fusion proteins and methods of use 吉利德科学公司 2023-08-01 CN disclosed
CN-116437958-A Method for identifying HIV patients susceptible to therapy with gp120 CD4 binding site directed antibodies 吉利德科学公司 2023-07-14 CN disclosed
CN-112218651-A Immunopotentiating RNA for combination with chimeric antigen receptor therapy 诺华公司 2021-01-12 CN disclosed